Shell plc
Shell plc (SHEL) Financial Performance & Income Statement Overview
Review Shell plc (SHEL) income statement, balance sheet, and cash flow reports with annual and quarterly breakdowns.
Shell plc (SHEL) Income Statement & Financial Overview
View the income breakdown for Shell plc SHEL across both annual and quarterly reports.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $69.23B | $66.28B | $71.09B | $74.46B |
| Cost of Revenue | $56.53B | $59.45B | $59.94B | $62.56B |
| Gross Profit | $12.71B | $6.83B | $11.15B | $11.90B |
| Gross Profit Ratio | $0.18 | $0.10 | $0.16 | $0.16 |
| R&D Expenses | $185.00M | $331.00M | $294.00M | $263.00M |
| SG&A Expenses | $2.84B | $3.23B | $3.14B | $3.09B |
| Operating Expenses | $3.23B | $4.42B | $3.74B | $3.85B |
| Total Costs & Expenses | $59.76B | $63.87B | $63.68B | $66.42B |
| Interest Income | $566.00M | $185.00M | $778.00M | $690.00M |
| Interest Expense | $1.12B | $1.28B | $1.17B | $1.24B |
| Depreciation & Amortization | $5.13B | $5.83B | $5.58B | $5.64B |
| EBITDA | $15.21B | $11.32B | $14.02B | $14.28B |
| EBITDA Ratio | $0.22 | $0.17 | $0.20 | $0.19 |
| Operating Income | $9.47B | $2.41B | $7.41B | $8.04B |
| Operating Income Ratio | $0.14 | $0.04 | $0.10 | $0.11 |
| Other Income/Expenses (Net) | -$512.00M | $1.79B | -$140.00M | -$641.00M |
| Income Before Tax | $8.96B | $4.21B | $7.27B | $7.40B |
| Income Before Tax Ratio | $0.13 | $0.06 | $0.10 | $0.10 |
| Income Tax Expense | $4.08B | $3.16B | $2.88B | $3.75B |
| Net Income | $4.78B | $928.00M | $4.29B | $3.52B |
| Net Income Ratio | $0.07 | $0.01 | $0.06 | $0.05 |
| EPS | $0.76 | $0.15 | $0.68 | $0.55 |
| Diluted EPS | $0.75 | $0.15 | $0.68 | $0.55 |
| Weighted Avg Shares Outstanding | $6.30B | $6.19B | $6.31B | $6.39B |
| Weighted Avg Shares Outstanding (Diluted) | $6.36B | $6.21B | $6.32B | $6.42B |
Over the past four quarters, Shell plc demonstrated steady revenue growth, increasing from $74.46B in Q2 2024 to $69.23B in Q1 2025. Operating income reached $9.47B in Q1 2025, maintaining a consistent 14% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $15.21B, reflecting operational efficiency. Net income rose to $4.78B, with EPS at $0.76. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan